Wala-Heilmittel GmbH

Address
Dorfstrasse 1+3, Eckwaelden

Sponsor Overview

assignment
1
sponsored trial
science
4
molecules
location_city
25
research centres
public
1
country
person_search
28
investigators

Specializations

Oncology Supportive Care

Wala-Heilmittel GmbH’s clinical research is centered on chemotherapy-induced polyneuropathy, with attention to symptom prevention and relief in people receiving oncological treatment.

  • Chemotherapy-induced peripheral neuropathy
  • Supportive care in cancer treatment
  • Neuropathic symptom reduction

The sponsor’s active trial focus is on protecting patients from treatment-related nerve damage and related discomfort during cancer therapy.

Neurology and Peripheral Nerve Health

The funded research addresses peripheral neuropathy associated with cancer therapy, reflecting interest in preserving nerve function and reducing sensory disturbances linked to neurotoxicity.

  • Peripheral nerve injury
  • Sensory neuropathic symptoms
  • Neuroprotective care

This area places emphasis on the clinical burden of tingling, pain, and functional impairment arising during systemic cancer treatment.

Patient Quality of Life

Another clear area of interest is the impact of CIPN on quality of life, including daily functioning, comfort, and treatment tolerance in oncology patients.

  • Symptom burden
  • Functional wellbeing
  • Treatment-related discomfort

The research landscape includes outcomes related to patient-reported improvement in neuropathy-associated limitations and distress.

Clinical Research Coordination

Based in Bad Boll, Germany, the sponsor coordinates multicentre clinical research across collaborating sites, with activity focused in a single country and a current recruiting study in the field of neuropathy prevention.

  • Multisite trial coordination
  • Recruitment in oncology research
  • Single-country clinical development

This operational profile supports clinical investigation in a targeted supportive-care setting for patients undergoing chemotherapy.

Sponsored Trials

Data & Insights

science
Molecule Portfolio
Compounds under investigation
2
Exclusive Molecules
out of 4 total (50% not shared with other sponsors)

This sponsor works with 4 molecules, of which 2 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 25 sites collaborated multiple times

This sponsor has worked with 25 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Nervous System Diseases1 trial
    449 other sponsors

Partnered Research Centres

25 centres
location_city
assignment5
Agaplesion Diakonieklinikum Rotenburg gGmbH
Address
Elise-Averdieck-Strasse 17, 27356 Rotenburg (Wümme)
Learn morearrow_forward
location_city
assignment49
Agaplesion Frankfurter Diakonie Kliniken gGmbH
Address
Wilhelm-Epstein-Strasse 4, Bockenheim, 60431 Frankfurt
Learn morearrow_forward
location_city
assignment18
DONAUISAR Klinikum Deggendorf-Dingolfing-Landau gKU
Address
Perlasberger Strasse 41, 94469 Deggendorf
Learn morearrow_forward
location_city
assignment1
Hansegyn GbR, Gynäkologische Praxisklinik Hamburg Harburg
Address
Hamburger Ring 10, 21073 Hamburg
Learn morearrow_forward
location_city
assignment29
Heidelberg University
Address
Theodor-Kutzer-Ufer 1-3, Wohlgelegen, 68167 Mannheim
Learn morearrow_forward
location_city
assignment487
Institut fuer Klinische Transfusionsmedizin und Immungenetik Ulm gGmbH
Address
Albert-Einstein-Allee 23, Eselsberg, 89081 Ulm
Learn morearrow_forward
Page 1 of 5

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Wala-Heilmittel GmbH.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.